Archive of Annals of the Rheumatic Diseases, a leading rheumatology journal previously published by BMJ.

Background: Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Its use has been associated with hypersensitivity pneumonitis and diffuse lung disease. Whether MTX ...

1 Institute of Toxicology and Pharmacology, University of Rostock, Rostock, Germany 2 Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University ...

7 Maastricht University Medical Center and CAPHRI Research Institute, Maastricht, The Netherlands Correspondence to Professor D van der Heijde, Department of Rheumatology, Leiden University Medical ...

Background: Since the 2015 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably. Objectives: The goal ...

Objective To examine familial aggregation of gout and to estimate the heritability and environmental contributions to gout susceptibility in the general population. Methods Using data from the ...

Psoriasis is a common chronic, recurrent, immune mediated disease of the skin and joints. It can have a significant negative impact on the physical, emotional, and, psychosocial wellbeing of affected ...

Lost in the system - how to use innovative care to bring health services back to the patient ...

Objectives To examine the safety and efficacy of rontalizumab, a humanised IgG1 anti-interferon α (anti-IFN-α) monoclonal antibody, in patients with moderate-to-severe systemic lupus erythematosus ...

3 Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y de la Nutricion, Salvador Zubiran, Mexico City, Mexico Correspondence to Dr Carmelo Carmona-Rivera, National ...

aDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt University, Berlin, Germany, bDepartment of Rheumatology and Physical Medicine, University Hospital, Zurich, ...

3 National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China Objectives To explore the relapse rate after glucocorticoid (GC) withdrawal with or without ...